Начало › Рак на яйчниците › Вирджиния › Arlington
Клинични проучвания за Рак на яйчниците в Arlington, VA
46 проучвания за Рак на яйчниците търсят участници в обекти в и около Arlington (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
The Vanguard Study: Testing a New Way to Screen for Cancer
Набиране на участнициЗдравите доброволци са добре дошли
- Inova Schar Cancer Institute, Fairfax · на 11 мили
- Inova Fair Oaks Hospital, Fairfax · на 11 мили
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Набиране на участнициФаза 2
- Inova Fairfax Hospital, Falls Church · на 4 мили
- Inova Schar Cancer Institute, Fairfax · на 11 мили
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Набиране на участнициФаза 1/2
- Research Site, Fairfax · на 11 мили
A Study of PHST001 in Advanced Solid Tumors
Набиране на участнициФаза 1
- NEXT Oncology - Virginia, Fairfax · на 11 мили
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1
- Inova Schar Cancer Institute, Fairfax · на 11 мили
- NEXT Virginia, Fairfax · на 11 мили
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Набиране на участнициФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 мили
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Набиране на участнициФаза 1
- NEXT Virginia, Fairfax · на 11 мили
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Набиране на участнициФаза 2
- Next Virginia /ID# 279684, Fairfax · на 11 мили
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Набиране на участнициФаза 1
- Site 04, Fairfax · на 11 мили
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Набиране на участнициФаза 1
- Next Virginia /ID# 278607, Fairfax · на 11 мили
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
Набиране на участнициФаза 1/2
- NEXT Virginia, Fairfax · на 11 мили
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Набиране на участнициФаза 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 276456, Fairfax · на 11 мили
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Набиране на участнициФаза 2
- Site 0322 - Inova Schar Cancer Institute, Fairfax · на 11 мили
Study of AVZO-021 in Patients With Advanced Solid Tumors
Набиране на участнициФаза 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · на 11 мили
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Набиране на участнициФаза 1/2
- NEXT Oncology Virginia, Fairfax · на 11 мили
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Набиране на участнициФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 мили
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Набиране на участнициФаза 3
- Virginia Cancer Specialists (VCS) ( Site 8012), Fairfax · на 11 мили
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Набиране на участнициФаза 1/2
- NEXT Oncology, Fairfax · на 11 мили
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Набиране на участнициФаза 3
- Inova Schar Cancer Institute, Fairfax · на 11 мили
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Набиране на участнициФаза 2
- Virginia Cancer Specialists, Fairfax · на 11 мили
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Набиране на участнициФаза 1/2
- Inova Schar Cancer Institute, Fairfax · на 11 мили
- Next Oncology Virginia, Fairfax · на 11 мили
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Набиране на участнициФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 мили
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
Набиране на участнициФаза 1
- NEXT Oncology, Fairfax · на 11 мили
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Набиране на участнициФаза 3
- Virginia Cancer Specialists (VCS) ( Site 8011), Fairfax · на 11 мили
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Набиране на участнициФаза 1
- Inova Schar Cancer Institute, Falls Church · на 4 мили
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Набиране на участнициФаза 1
- Normunity Investigational Site, Fairfax · на 11 мили
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Набиране на участници
- Inova Fairfax Hospital, Falls Church · на 4 мили
- Inova Schar Cancer Institute, Fairfax · на 11 мили
- Inova Fair Oaks Hospital, Fairfax · на 11 мили
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1/2
- Clinical Trial Site, Fairfax · на 11 мили
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Набиране на участнициФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 мили
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · на 11 мили
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Набиране на участнициФаза 1/2
- USOR Virginia Cancer Specialists, Fairfax · на 11 мили
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 мили
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Набиране на участнициФаза 1
- NEXT Virginia, Fairfax · на 11 мили
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Набиране на участнициФаза 2
- 522, Fairfax · на 11 мили
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · на 11 мили
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
Набиране на участнициФаза 1
- NEXT Virginia, Fairfax · на 11 мили
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Набиране на участнициФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 мили
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Набиране на участнициФаза 1/2
- NEXT Oncology Virginia, Fairfax · на 11 мили
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1/2
- NEXT, Fairfax · на 11 мили
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Набиране на участнициФаза 3
- Inova Schar Cancer Institute, Fairfax · на 11 мили
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Набиране на участнициФаза 1
- NEXT Oncology Virginia, Fairfax · на 11 мили
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Набиране на участнициФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 мили
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Набиране на участнициФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 мили
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
Набиране на участнициФаза 1
- NEXT Oncology, Fairfax · на 11 мили
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Набиране на участнициФаза 1
- Dren Investigational Site, Fairfax · на 11 мили
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
Набиране на участнициФаза 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · на 11 мили
Проучвания за Рак на яйчниците в други градове
- Houston, TX89 проучвания
- New York City, NY69 проучвания
- Boston, MA61 проучвания
- Los Angeles, CA50 проучвания
- Nashville, TN49 проучвания
- Philadelphia, PA44 проучвания
- Columbus, OH39 проучвания
- St. Louis, MO38 проучвания
- Chicago, IL36 проучвания
- San Antonio, TX31 проучвания
- Cleveland, OH30 проучвания
- Pittsburgh, PA30 проучвания
Други проучвания в Arlington
- Рак на белия дроб с недребноклетъчен тип104 проучвания
- Метастатичен рак53 проучвания
- Колоректален рак52 проучвания
- Рак (всички видове)48 проучвания
- Рак на гърдата47 проучвания
- Рак на белия дроб41 проучвания
- Ендометриален рак39 проучвания
- Рак на панкреаса33 проучвания
- Плоскоклетъчен карцином на главата и шията26 проучвания
- Дребноклетъчен белодробен рак23 проучвания
- Рак на стомаха20 проучвания
- Тройно негативен рак на гърдата20 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.